ACADIA Pharmaceuticals (ACAD) Stock Highlights

16.87 | +0.84%

2024-12-21 03:04:58

Acadia Pharmaceuticals is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecule drugs that address disorders such as Parkinsons, Alzheimers, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The companys patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.

Statistics

Range Today

16.49 17.21

Volume Today 4.94M

Range 1 Year

14.15 32.59

Volume 1 Year 418.61M

Range 3 Year

12.24 33.99

Volume 3 Year 1.27B

Range 10 Year

12.24 58.72

Volume 10 Year 4.59B

Highlights

Market Capitalization 2.94B (mid)

Floating Shares 108.52M

Current Price 16.87

Price To Earnings 21.38

Price To Revenue 2.59

Price To Book 5.08

Earnings Per Share 0.8

Payout Ratio 0%

Performance

Latest +0.84%

1 Month +3.82%

3 Months +2.8%

6 Months +13.45%

1 Year -43.92%

3 Years -33.84%

5 Years -61.4%

10 Years -48.65%

Benchmarks

Market Capitalization

40 / 368

Gross Profits

40 / 278

Total Revenue

22 / 300

Total Rank

107 / 368

Free Cashflow

200 / 352

Performance 5 years

185 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.